Nhwa Pharmaceutical
SZSE · 002262
Market Cap$19.7B
Revenue$6.0B
Employees6003
Listed OnSZSE
Ticker002262
CEO / ExecMr. Jiaquan Sun
HeadquartersXuzhou
MarketMainland China
Websitewww.nhwa-group.com
Overview
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapin
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.